# Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases

> **NCT00156975** · PHASE3 · UNKNOWN · sponsor: **Arbeitsgruppe Lebermetastasen und Tumoren** · enrollment: 384 (—)

## Conditions studied

- Colorectal Neoplasms
- Liver Metastases

## Interventions

- **DRUG:** Capecitabine
- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT00156975
- **Lead sponsor:** Arbeitsgruppe Lebermetastasen und Tumoren
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 384 (—)
- **Last updated:** 2009-12-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00156975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00156975, "Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00156975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*